13F Data
13F filer · CIK 1906602

Alpine Peaks Capital, LP

NEW YORK, NY · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$85.4M
$-13.8M vs prior
Positions
20
New / sold out
1 / 2
Added / reduced
1 / 18
Turnover
1.2%
buys $1.1M · sells $27.5M
Top-10 weight
65.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewCELSIUS HLDGS INC+26,332–+$771.0K
AddedHENRY JACK & ASSOC INC+2,233+6.9%+$307.6K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedWEST PHARMACEUTICAL SVSC INC-10,692-35.8%$-3.8M
ReducedQUALYS INC-24,763-70.9%$-3.4M
ReducedLITTELFUSE INC-6,203-36.3%$-2.8M
ReducedCOGNEX CORP-32,320-26.5%$-2.3M
Sold outTRINET GROUP INC-45,650-100.0%$-1.7M
ReducedWABTEC-5,825-33.3%$-1.6M
ReducedTREX INC-30,577-25.0%$-1.5M
ReducedHEICO CORP NEW-5,301-15.7%$-1.4M
ReducedINTERPARFUMS INC-11,480-30.9%$-1.3M
ReducedU S PHYSICAL THERAPY-18,537-19.5%$-1.3M
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $102.2MQ1 2022: $97.2MQ2 2022: $85.7MQ3 2022: $111.4MQ4 2022: $123.5MQ1 2023: $132.4MQ2 2023: $142.5MQ3 2023: $143.4MQ4 2023: $164.6MQ1 2024: $173.6MQ2 2024: $162.9MQ3 2024: $167.5MQ4 2024: $121.8MQ1 2025: $110.9MQ2 2025: $113.3MQ3 2025: $115.2MQ4 2025: $105.0MQ1 2026: $99.2MQ2 2026: $85.4M
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1HEICO CORP NEWCL A28,368$7.3M8.57%
2WEST PHARMACEUTICAL SVSC INCCOM19,191$6.9M8.07%
3COGNEX CORPCOM89,599$6.5M7.60%
4BRIGHT HORIZONS FAM SOL IN DCOM77,539$5.5M6.44%
5U S PHYSICAL THERAPYCOM76,487$5.3M6.15%
6MEDPACE HLDGS INCCOM9,418$5.0M5.84%
7LITTELFUSE INCCOM10,897$5.0M5.81%
8HENRY JACK & ASSOC INCCOM34,480$4.7M5.56%
9BIO-TECHNE CORPCOM66,960$4.7M5.54%
10TREX INCCOM91,762$4.6M5.38%
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.